Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$1,958,130
+$25,938 QoQ
Shares Held
1,717,659
+23.6% QoQ
Ownership
0.620%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 170 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Derivatives in AKBA

reported options exposure · as of Jun 30, 2026
CallValue
$110,580
CallShares
97,000
PutValue
$190,608
PutShares
167,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,824 across 65 Drug Manufacturers - Specialty & Generic names. AKBA ranks #34 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in AKBA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $110,580 97,000
2026-06-30 $190,608 167,200
2026-06-30 $1,958,130 1,717,659
2026-03-31 $219,759 158,100
2026-03-31 $1,932,192 1,390,067
2026-03-31 $247,698 178,200
2025-12-31 $236,187 146,700
2025-12-31 $340,837 211,700
2025-12-31 $7,511,513 4,665,537
2025-09-30 $8,697,304 3,185,826
2025-09-30 $288,561 105,700
2025-09-30 $628,446 230,200
2025-06-30 $8,434,935 2,317,290
2025-06-30 $147,784 40,600
2025-06-30 $668,668 183,700
2025-03-31 $7,002,064 3,646,909
2025-03-31 $71,040 37,000
2025-03-31 $285,504 148,700
2024-12-31 $170,620 89,800
2024-12-31 $2,626,077 1,382,146
2024-12-31 $44,460 23,400
2024-09-30 $168,300 127,500
2024-09-30 $93,984 71,200
2024-06-30 $93,636 91,800
2024-06-30 $79,050 77,500
2024-06-30 $218,962 214,669
2024-03-31 $247,233 135,100
2024-03-31 $377,163 206,100
2024-03-31 $152,318 83,234
2023-12-31 $233,856 188,594
2023-12-31 $172,980 139,500
2023-12-31 $131,564 106,100
2023-09-30 $60,648 53,200
2023-09-30 $146,262 128,300
2023-06-30 $882 965
2023-06-30 $34,678 37,900
2023-06-30 $100,101 109,400
2023-03-31 $21,112 37,700
2023-03-31 $41,888 74,800
2022-12-31 $51,468 89,200
2022-12-31 $7,730 13,397
2022-12-31 $10,963 19,000
2022-09-30 $23,731 75,100
2022-09-30 $95,170 301,174
2022-09-30 $10,270 32,500
2022-06-30 $55,138 156,200
2022-06-30 $161,427 457,303
2022-06-30 $9,213 26,100
2022-03-31 $114,018 158,800
2022-03-31 $328,628 457,700